GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Price-to-Tangible-Book

NKGen Biotech (NKGen Biotech) Price-to-Tangible-Book : (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Price-to-Tangible-Book?

As of today (2024-05-26), NKGen Biotech's share price is $1.42. NKGen Biotech's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-2.46. Hence, NKGen Biotech's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for NKGen Biotech's Price-to-Tangible-Book or its related term are showing as below:

NKGN's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, NKGen Biotech's share price is $1.42. NKGen Biotech's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-2.46. Hence, NKGen Biotech's P/B Ratio of today is .

NKGen Biotech Price-to-Tangible-Book Historical Data

The historical data trend for NKGen Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Price-to-Tangible-Book Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - -

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial - - - - -

Competitive Comparison of NKGen Biotech's Price-to-Tangible-Book

For the Biotechnology subindustry, NKGen Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NKGen Biotech's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's Price-to-Tangible-Book falls into.


NKGen Biotech Price-to-Tangible-Book Calculation

NKGen Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=1.42/-2.463
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

NKGen Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Price-to-Tangible-Book
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.